In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells
about
IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysisCellular actions of insulin-like growth factor binding proteins.Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancerPlasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer.Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-IInteraction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model.IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.Regulatory functions of insulin-like growth factor binding proteins in osteoarthritis.The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells.Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity.Insulin-like growth factors in breast cancer.Damage control mechanisms in articular cartilage: the role of the insulin-like growth factor I axis.Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery.Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis?
P2860
Q28616752-D9C36AFE-04A5-4AD2-85EF-BDB042A2CD31Q33607372-745EDF9B-7D44-4B89-841C-552544CA1456Q33853206-867EB5B3-83EF-43EB-A399-0F6D51524F13Q33890792-8EA6FE7F-20F0-490E-8A0B-0FF94B7DDC7BQ36618953-CD4E53A0-1E24-45D2-A095-C2AFB081D6EFQ36623079-43425BA3-4EEA-4816-A62C-EF7AB39F08FBQ36904666-0233F05A-9710-42F3-9EA5-EFCDA0AD638AQ37361728-373F3B8F-0CEE-4921-BB14-E29B6DCCFF58Q37829755-0834B02F-FA41-4072-98E7-0077AAD628C7Q37888841-D3992621-A3EB-4F8E-8E25-1F9BC02A6EEFQ38327469-2B46353C-B268-4C01-B677-DA949509B0B9Q38334516-48762FE5-5E4F-46F4-A02C-0B68E89BE6FAQ41013044-C79BA412-C72B-4195-8081-372174E42693Q41463854-AFC499E9-8A48-4D44-8A1E-3BA13B74848EQ42491727-3833DBAC-85BD-47B3-BC5E-8A80EECDEA8CQ43733896-BBE59CF0-05CA-49C1-BCC2-8873569051B4Q43833838-75A18E69-E900-4A7F-A26B-9709AFEF5D54
P2860
In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
In vivo proteolysis of serum i ...... ability of IGF to target cells
@ast
In vivo proteolysis of serum i ...... ability of IGF to target cells
@en
In vivo proteolysis of serum insulin-like growth factor
@nl
type
label
In vivo proteolysis of serum i ...... ability of IGF to target cells
@ast
In vivo proteolysis of serum i ...... ability of IGF to target cells
@en
In vivo proteolysis of serum insulin-like growth factor
@nl
prefLabel
In vivo proteolysis of serum i ...... ability of IGF to target cells
@ast
In vivo proteolysis of serum i ...... ability of IGF to target cells
@en
In vivo proteolysis of serum insulin-like growth factor
@nl
P2093
P2860
P356
P1476
In vivo proteolysis of serum i ...... ability of IGF to target cells
@en
P2093
P2860
P304
P356
10.1172/JCI117229
P407
P577
1994-05-01T00:00:00Z